financetom
Business
financetom
/
Business
/
Akari Therapeutics Names Samir Patel Chief Executive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Akari Therapeutics Names Samir Patel Chief Executive
Dec 18, 2024 8:39 AM

11:15 AM EST, 12/18/2024 (MT Newswires) -- Akari Therapeutics ( AKTX ) said Wednesday it has named Samir Patel chief executive, effective Dec. 16.

Patel served as interim CEO of Akari Therapeutics ( AKTX ) since May. He currently serves as founder and principal of PranaBio Investments.

Price: 1.01, Change: +0.01, Percent Change: +1.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Lilly to Only Work With Telehealth Companies That Don't Sell Copycat Zepbound, Bloomberg Reports
--Lilly to Only Work With Telehealth Companies That Don't Sell Copycat Zepbound, Bloomberg Reports
Jun 10, 2025
01:20 PM EDT, 06/10/2025 (MT Newswires) -- Price: 803.70, Change: +30.12, Percent Change: +3.89 ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Novo Nordisk Launches Long-Term Study of CagriSema for Weight Loss; Shares Rise
Novo Nordisk Launches Long-Term Study of CagriSema for Weight Loss; Shares Rise
Jun 10, 2025
01:16 PM EDT, 06/10/2025 (MT Newswires) -- Novo Nordisk ( NVO ) has launched a new late-stage clinical trial to evaluate how well its experimental obesity drug CagriSema helps patients lose weight and maintain weight loss over the long term. The trial, listed on ClinicalTrials.gov on Monday, will span approximately three years and three months and includes two parts comprising...
Meta to pay nearly $15 billion for Scale AI stake, The Information reports
Meta to pay nearly $15 billion for Scale AI stake, The Information reports
Jun 10, 2025
(Reuters) -Meta Platforms ( META ) has agreed to take a 49% stake in artificial intelligence startup Scale AI for $14.8 billion, The Information reported on Tuesday, citing two people familiar with the matter. Founded in 2016, Scale AI provides vast amounts of labeled data or curated training data, which is crucial for developing sophisticated tools such as OpenAI's ChatGPT....
Copyright 2023-2026 - www.financetom.com All Rights Reserved